Older Emergency Department Users and Short-term Adverse Events at the Index Visit

Hospitalization Clinical Trial

Official title:

Older Emergency Department Users and Short-term Adverse Events at the Index Visit: Which Clinical Prognostic Tool is Used?

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04018898
• Other study ID #: 2020-1881
• Status: Active, not recruiting
• Start date: July 23, 2019
• Est. completion date: December 1, 2025

Study information

• Verified date: February 2024
• Source: Jewish General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study evaluates the difference between PRISMA-7 and ER2 tool. There are some differences between PRISMA-7 and ER2 tool. The differences consist in evaluation criteria that are used to perform the both surveys. We suppose that evaluation criteria of PRISMA-7 is not accurately enough to calculate the length of hospital stay and to predict the short-term outcomes.

Description:

The "Program of Research on Integration of Services for the Maintenance of Autonomy" (PRISMA-7) is the Ministry of Health and Social Services' reference tool for the assessment of older ED users in Quebec (Canada). PRISMA-7 has been initially designed to screen disability in community-dwelling older adults and has never been validated for risk for short-term adverse events in older ED users. "Emergency room evaluation and recommendations" (ER2) is another clinical tool which is currently evaluated in Quebec. Compared to PRISMA-7, ER2 has been especially designed for assessing risk for short-term ED adverse events. No study has compared PRISMA-7 and ER2 risk for short-term adverse events. We hypothesised that ER2 could be a better prognostic tool compared to PRISMA-7 for long length of stay in ED and hospital stay, and hospital admission because it was designed and validated for this specific goal. The study aims to 1) examine and compared PRISMA-7 and ER2 risk for long length of ED and hospital stay and hospital admission, and 2) to establish their performance criteria (i.e., sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios) for these three short-term adverse events in older ED users.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 10971
• Est. completion date: December 1, 2025
• Est. primary completion date: March 1, 2024
• Gender: All
• Age group: 75 Years and older

Eligibility

Inclusion Criteria:

• Being 75 years old and over
• Brought at Emergency on medical stretcher

Exclusion Criteria:

• Being less than 75 years old
• Never come at Emergency

Related Conditions & MeSH terms

• Adverse Event
• Emergencies
• Health Impairment
• Hospitalization

Locations

Country	Name	City	State
Canada	Jewish General Hospital	Montréal	Quebec

Sponsors (1)

Lead Sponsor	Collaborator
Jewish General Hospital

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Short-term adverse events	The adverse event is defined as an adverse outcome related to an ED encounter, this adverse event is related to ED care.	Around 10 months